Helicoverpa zea isolate HzStark_Cry1AcR chromosome 4, ilHelZeax1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Noctuoidea; Noctuidae; Heliothinae; Helicoverpa.
REFSEQ INFORMATION: The reference sequence is identical to\nCM040206.1.\nAssembly name: ilHelZeax1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the United States Department of\nAgriculture on 2022/03/18. The original whole-genome shotgun\nproject has the accession JAKYJW000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: United States Department of Agriculture\nAssembly Date :: 31-DEC-2021\nAssembly Method :: FALCON v. 1.8.1; FALCON-Unzip v. 1.3.7;\n purge_dups v. 1.2.5; bwa-mem v. 2.2.1;\n Juicebox v. 1.11.08; Arrow gcpp v. 2.0.2;\n FreeBayes v. 1.0.2; Merqury v. 1.1\nAssembly Name :: ilHelZeax1.1\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 144x\nSequencing Technology :: PacBio Sequel II CLR; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Helicoverpa zea Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
laboratory colony at USDA ARS Southern Insect Management Unit, Stoneville, MS
USDA-ARS Genetics and Sustainability Agricultural Research Unit, Starkville, MS, USA
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized protein LOC124629937 isoform X4
uncharacterized protein LOC124629937 isoform X3
uncharacterized LOC124629873, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124629873, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124629873, transcript variant X1
uncharacterized LOC124629873, transcript variant X2
uncharacterized LOC124629873, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124629823, transcript variant X1
uncharacterized LOC124629823, transcript variant X2
uncharacterized protein LOC124629823 isoform X1
uncharacterized protein LOC124629823 isoform X2
translation initiation factor IF-2, transcript variant X4
translation initiation factor IF-2, transcript variant X3
translation initiation factor IF-2, transcript variant X1
translation initiation factor IF-2 isoform X1
uncharacterized protein LOC124629824 isoform X3
translation initiation factor IF-2, transcript variant X5
translation initiation factor IF-2, transcript variant X2
translation initiation factor IF-2 isoform X2
uncharacterized LOC124629511, transcript variant X2
uncharacterized LOC124629511, transcript variant X1
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like, transcript variant X1
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like, transcript variant X2
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like isoform X2
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
fork head domain transcription factor slp2-like
uncharacterized LOC124630087, transcript variant X1
uncharacterized LOC124630087, transcript variant X3
uncharacterized LOC124630087, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ubiquitin thioesterase otubain-like, transcript variant X2
ubiquitin thioesterase otubain-like, transcript variant X1
ubiquitin thioesterase otubain-like isoform X2
ubiquitin thioesterase otubain-like isoform X1
apoptosis-resistant E3 ubiquitin protein ligase 1, transcript variant X1
apoptosis-resistant E3 ubiquitin protein ligase 1, transcript variant X2
apoptosis-resistant E3 ubiquitin protein ligase 1 isoform X1
apoptosis-resistant E3 ubiquitin protein ligase 1 isoform X2
transcription factor p65, transcript variant X1
transcription factor p65, transcript variant X2
transcription factor p65, transcript variant X6
transcription factor p65, transcript variant X3
transcription factor p65, transcript variant X4
transcription factor p65, transcript variant X5
transcription factor p65, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124630027, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124630027, transcript variant X1
uncharacterized protein LOC124630027 isoform X1
uncharacterized protein LOC124630027 isoform X2
probable basic-leucine zipper transcription factor R
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
activating signal cointegrator 1 complex subunit 2 homolog
protein croquemort-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
protein croquemort-like, transcript variant X1
protein croquemort-like, transcript variant X2
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein peste-like, transcript variant X2
protein peste-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 24% coverage of the annotated genomic feature by RNAseq alignments
muscle-specific protein 300 kDa-like, transcript variant X3
muscle-specific protein 300 kDa-like, transcript variant X8
muscle-specific protein 300 kDa-like, transcript variant X5
muscle-specific protein 300 kDa-like, transcript variant X6
muscle-specific protein 300 kDa-like, transcript variant X2
muscle-specific protein 300 kDa-like, transcript variant X4
muscle-specific protein 300 kDa-like, transcript variant X1
muscle-specific protein 300 kDa-like isoform X3
muscle-specific protein 300 kDa-like isoform X7
muscle-specific protein 300 kDa-like isoform X5
muscle-specific protein 300 kDa-like isoform X6
muscle-specific protein 300 kDa-like isoform X2
muscle-specific protein 300 kDa-like isoform X4
muscle-specific protein 300 kDa-like isoform X1
muscle-specific protein 300 kDa-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
STE20-related kinase adapter protein alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
tRNA (guanosine(18)-2'-O)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX28
gamma-aminobutyric acid type B receptor subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
arrestin domain-containing protein 17-like
arrestin domain-containing protein 3-like
arrestin domain-containing protein 2-like
arrestin domain-containing protein 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: arrestin domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
putative fatty acyl-CoA reductase CG5065
excitatory amino acid transporter, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excitatory amino acid transporter, transcript variant X2
excitatory amino acid transporter, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excitatory amino acid transporter isoform X1
excitatory amino acid transporter isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
TBC1 domain family member 15, transcript variant X2
TBC1 domain family member 15, transcript variant X1
TBC1 domain family member 15, transcript variant X5
TBC1 domain family member 15, transcript variant X4
TBC1 domain family member 15, transcript variant X3
TBC1 domain family member 15, transcript variant X6
TBC1 domain family member 15, transcript variant X7
histone acetyltransferase KAT7, transcript variant X2
histone acetyltransferase KAT7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
activity-regulated cytoskeleton associated protein 1-like
cGMP-dependent 3',5'-cyclic phosphodiesterase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124629949, transcript variant X2
uncharacterized LOC124629949, transcript variant X1
uncharacterized LOC124629949, transcript variant X3
uncharacterized protein LOC124629949 isoform X2
uncharacterized protein LOC124629949 isoform X1
uncharacterized protein LOC124629949 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
N-acetylgalactosaminyltransferase 7, transcript variant X1
N-acetylgalactosaminyltransferase 7 isoform X1
N-acetylgalactosaminyltransferase 7, transcript variant X2
N-acetylgalactosaminyltransferase 7 isoform X2
tubulin-specific chaperone C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tubulin-specific chaperone C, transcript variant X1
tubulin-specific chaperone C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mesoderm induction early response protein 1
endoplasmic reticulum lectin 1, transcript variant X1
endoplasmic reticulum lectin 1, transcript variant X3
endoplasmic reticulum lectin 1, transcript variant X2
endoplasmic reticulum lectin 1 isoform X1
endoplasmic reticulum lectin 1 isoform X3
endoplasmic reticulum lectin 1 isoform X2
CUGBP Elav-like family member 1, transcript variant X1
CUGBP Elav-like family member 1, transcript variant X3
CUGBP Elav-like family member 1, transcript variant X2
CUGBP Elav-like family member 1, transcript variant X5
CUGBP Elav-like family member 1, transcript variant X6
CUGBP Elav-like family member 1, transcript variant X4
CUGBP Elav-like family member 1 isoform X5
CUGBP Elav-like family member 1 isoform X3
CUGBP Elav-like family member 1 isoform X2
CUGBP Elav-like family member 1 isoform X1
CUGBP Elav-like family member 1 isoform X6
CUGBP Elav-like family member 1 isoform X4
uncharacterized LOC124629505, transcript variant X2
uncharacterized LOC124629505, transcript variant X1
uncharacterized LOC124629505, transcript variant X3
uncharacterized protein LOC124629505 isoform X2
uncharacterized protein LOC124629505 isoform X1
uncharacterized protein LOC124629505 isoform X3
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like, transcript variant X2
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X1
sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and SCAN domain-containing protein 21-like
nose resistant to fluoxetine protein 6-like
ATP-binding cassette subfamily G member 4-like, transcript variant X2
ATP-binding cassette subfamily G member 4-like, transcript variant X1
ATP-binding cassette subfamily G member 4-like isoform X2
ATP-binding cassette subfamily G member 4-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hemicentin-1-like, transcript variant X1
hemicentin-1-like, transcript variant X2
O-acyltransferase like protein-like, transcript variant X1
O-acyltransferase like protein-like, transcript variant X2
O-acyltransferase like protein-like isoform X1
O-acyltransferase like protein-like isoform X2
leucine-rich PPR motif-containing protein, mitochondrial
uncharacterized LOC124629563, transcript variant X2
uncharacterized LOC124629563, transcript variant X1
uncharacterized LOC124629563, transcript variant X3
uncharacterized protein LOC124629563 isoform X2
uncharacterized protein LOC124629563 isoform X1
uncharacterized protein LOC124629563 isoform X3
WW domain-containing oxidoreductase-like
synaptic vesicle glycoprotein 2B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like isoform X1
solute carrier family 22 member 12-like isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 90
nucleoside diphosphate kinase homolog 5-like
pituitary homeobox homolog Ptx1, transcript variant X2
pituitary homeobox homolog Ptx1, transcript variant X1
pituitary homeobox homolog Ptx1 isoform X2
pituitary homeobox homolog Ptx1 isoform X1
progestin and adipoQ receptor family member 3
uncharacterized LOC124629866, transcript variant X2
uncharacterized LOC124629866, transcript variant X3
uncharacterized LOC124629866, transcript variant X1
uncharacterized protein LOC124629866 isoform X2
uncharacterized protein LOC124629866 isoform X3
uncharacterized protein LOC124629866 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
circadian clock-controlled protein daywake-like, transcript variant X1
circadian clock-controlled protein daywake-like, transcript variant X2
circadian clock-controlled protein daywake-like isoform X1
circadian clock-controlled protein daywake-like isoform X2
mitogen-activated protein kinase kinase kinase 15, transcript variant X2
mitogen-activated protein kinase kinase kinase 15, transcript variant X1
mitogen-activated protein kinase kinase kinase 15, transcript variant X3
mitogen-activated protein kinase kinase kinase 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 10% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCHC domain-containing protein 24-like
phenoloxidase-activating enzyme 1-like, transcript variant X1
phenoloxidase-activating enzyme 1-like, transcript variant X2
phenoloxidase-activating enzyme 1-like isoform X1
phenoloxidase-activating enzyme 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein DDB_G0290685-like
uncharacterized LOC124630003, transcript variant X2
uncharacterized LOC124630003, transcript variant X1
uncharacterized protein LOC124630003 isoform X2
uncharacterized protein LOC124630003 isoform X1
protein argonaute-2-like, transcript variant X3
protein argonaute-2-like, transcript variant X2
protein argonaute-2-like, transcript variant X1
sodium/hydrogen exchanger 9B2-like, transcript variant X4
sodium/hydrogen exchanger 9B2-like, transcript variant X2
sodium/hydrogen exchanger 9B2-like, transcript variant X1
sodium/hydrogen exchanger 9B2-like, transcript variant X3
sodium/hydrogen exchanger 9B2-like isoform X2
sodium/hydrogen exchanger 9B2-like isoform X1
three prime repair exonuclease 2-like, transcript variant X3
three prime repair exonuclease 2-like, transcript variant X4
three prime repair exonuclease 2-like, transcript variant X2
three prime repair exonuclease 2-like isoform X2
three prime repair exonuclease 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
three prime repair exonuclease 2-like isoform X1
aldehyde dehydrogenase X, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
inactive pancreatic lipase-related protein 1-like, transcript variant X4
inactive pancreatic lipase-related protein 1-like, transcript variant X3
inactive pancreatic lipase-related protein 1-like, transcript variant X2
inactive pancreatic lipase-related protein 1-like, transcript variant X1
inactive pancreatic lipase-related protein 1-like isoform X3
inactive pancreatic lipase-related protein 1-like isoform X4
pancreatic lipase-related protein 2-like isoform X2
pancreatic lipase-related protein 2-like isoform X1
androgen-dependent TFPI-regulating protein-like
ATP-binding cassette sub-family G member 1, transcript variant X1
ATP-binding cassette sub-family G member 1, transcript variant X2
ATP-binding cassette sub-family G member 1
ATP-binding cassette subfamily G member 4-like, transcript variant X3
ATP-binding cassette sub-family G member 4-like, transcript variant X1
ATP-binding cassette sub-family G member 4-like isoform X1
ATP-binding cassette sub-family G member 4-like, transcript variant X2
ATP-binding cassette sub-family G member 4-like isoform X2
alpha-amylase 3-like, transcript variant X1
alpha-amylase 3-like, transcript variant X2
uncharacterized protein LOC124629582 isoform X1
carnitine O-palmitoyltransferase 2, mitochondrial
transmembrane protein 145, transcript variant X1
transmembrane protein 145, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
phosphatidylinositol 3-kinase regulatory subunit gamma, transcript variant X1
phosphatidylinositol 3-kinase regulatory subunit gamma, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit gamma
serine/arginine-rich splicing factor 7-like, transcript variant X1
serine/arginine-rich splicing factor 7-like
serine/arginine-rich splicing factor 7-like, transcript variant X2
uncharacterized LOC124629884, transcript variant X2
uncharacterized LOC124629884, transcript variant X1
juvenile hormone acid O-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
juvenile hormone acid O-methyltransferase-like, transcript variant X1
juvenile hormone acid O-methyltransferase-like, transcript variant X2
juvenile hormone acid O-methyltransferase-like
dachshund homolog 2, transcript variant X4
dachshund homolog 2, transcript variant X10
dachshund homolog 2, transcript variant X9
dachshund homolog 2, transcript variant X8
dachshund homolog 2, transcript variant X7
dachshund homolog 2, transcript variant X6
dachshund homolog 2, transcript variant X3
dachshund homolog 2, transcript variant X2
dachshund homolog 2, transcript variant X1
dachshund homolog 2, transcript variant X11
dachshund homolog 2, transcript variant X5
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X1
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X2
prolyl 4-hydroxylase subunit alpha-1-like
phosphoinositide 3-kinase adapter protein 1, transcript variant X2
phosphoinositide 3-kinase adapter protein 1 isoform X2
phosphoinositide 3-kinase adapter protein 1, transcript variant X1
phosphoinositide 3-kinase adapter protein 1 isoform X1
non-lysosomal glucosylceramidase, transcript variant X1
non-lysosomal glucosylceramidase, transcript variant X2
non-lysosomal glucosylceramidase isoform X1
non-lysosomal glucosylceramidase isoform X2
T-cell activation inhibitor, mitochondrial-like, transcript variant X2
T-cell activation inhibitor, mitochondrial-like, transcript variant X1
T-cell activation inhibitor, mitochondrial-like isoform X1
T-cell activation inhibitor, mitochondrial-like isoform X2
protein decapentaplegic, transcript variant X2
protein decapentaplegic, transcript variant X1
protein decapentaplegic, transcript variant X3
39S ribosomal protein L46, mitochondrial
60S ribosomal protein L9, transcript variant X1
60S ribosomal protein L9, transcript variant X2
disks large 1 tumor suppressor protein, transcript variant X20
disks large 1 tumor suppressor protein, transcript variant X7
disks large 1 tumor suppressor protein, transcript variant X6
disks large 1 tumor suppressor protein, transcript variant X5
disks large 1 tumor suppressor protein, transcript variant X2
disks large 1 tumor suppressor protein, transcript variant X4
disks large 1 tumor suppressor protein, transcript variant X3
disks large 1 tumor suppressor protein, transcript variant X1
disks large 1 tumor suppressor protein, transcript variant X9
disks large 1 tumor suppressor protein, transcript variant X8
disks large 1 tumor suppressor protein, transcript variant X18
disks large 1 tumor suppressor protein, transcript variant X12
disks large 1 tumor suppressor protein, transcript variant X10
disks large 1 tumor suppressor protein, transcript variant X17
disks large 1 tumor suppressor protein, transcript variant X13
disks large 1 tumor suppressor protein, transcript variant X16
disks large 1 tumor suppressor protein, transcript variant X19
disks large 1 tumor suppressor protein, transcript variant X15
disks large 1 tumor suppressor protein, transcript variant X14
disks large 1 tumor suppressor protein, transcript variant X11
disks large 1 tumor suppressor protein isoform X18
disks large 1 tumor suppressor protein isoform X7
disks large 1 tumor suppressor protein isoform X4
disks large 1 tumor suppressor protein isoform X6
disks large 1 tumor suppressor protein isoform X3
disks large 1 tumor suppressor protein isoform X9
disks large 1 tumor suppressor protein isoform X5
disks large 1 tumor suppressor protein isoform X2
disks large 1 tumor suppressor protein isoform X8
disks large 1 tumor suppressor protein isoform X1
disks large 1 tumor suppressor protein isoform X11
disks large 1 tumor suppressor protein isoform X14
disks large 1 tumor suppressor protein isoform X10
disks large 1 tumor suppressor protein isoform X15
disks large 1 tumor suppressor protein isoform X16
disks large 1 tumor suppressor protein isoform X13
disks large 1 tumor suppressor protein isoform X17
disks large 1 tumor suppressor protein isoform X12
calcium/calmodulin-dependent protein kinase type 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transport and Golgi organization protein 1, transcript variant X1
transport and Golgi organization protein 1, transcript variant X2
transport and Golgi organization protein 1 isoform X1
transport and Golgi organization protein 1 isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase assembly protein COX20, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
WD repeat and FYVE domain-containing protein 3, transcript variant X4
WD repeat and FYVE domain-containing protein 3, transcript variant X2
WD repeat and FYVE domain-containing protein 3, transcript variant X3
WD repeat and FYVE domain-containing protein 3, transcript variant X1
WD repeat and FYVE domain-containing protein 3 isoform X4
WD repeat and FYVE domain-containing protein 3 isoform X2
WD repeat and FYVE domain-containing protein 3 isoform X3
WD repeat and FYVE domain-containing protein 3 isoform X1
cysteine and histidine-rich domain-containing protein morgana
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein dissatisfaction
aminoacylase-1-like, transcript variant X3
aminoacylase-1-like, transcript variant X2
aminoacylase-1-like, transcript variant X4
aminoacylase-1-like, transcript variant X1
modifier of mdg4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
modifier of mdg4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC124630112 isoform X2
L-2-hydroxyglutarate dehydrogenase, mitochondrial, transcript variant X1
L-2-hydroxyglutarate dehydrogenase, mitochondrial, transcript variant X2
L-2-hydroxyglutarate dehydrogenase, mitochondrial
post-GPI attachment to proteins factor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124629489, transcript variant X1
uncharacterized protein LOC124629489 isoform X1
uncharacterized LOC124629489, transcript variant X2
uncharacterized protein LOC124629489 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
glucose dehydrogenase [FAD, quinone]-like
uncharacterized LOC124629559, transcript variant X2
uncharacterized LOC124629559, transcript variant X1
uncharacterized protein LOC124629559 isoform X2
uncharacterized protein LOC124629559 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
5'-AMP-activated protein kinase subunit beta-1, transcript variant X2
5'-AMP-activated protein kinase subunit beta-1, transcript variant X1
5'-AMP-activated protein kinase subunit beta-1 isoform X2
5'-AMP-activated protein kinase subunit beta-1 isoform X1
proton-coupled amino acid transporter-like protein pathetic
acyl-CoA Delta-9 desaturase-like, transcript variant X1
acyl-CoA Delta-9 desaturase-like, transcript variant X2
breast cancer type 1 susceptibility protein-like, transcript variant X2
breast cancer type 1 susceptibility protein-like, transcript variant X1
breast cancer type 1 susceptibility protein-like isoform X2
breast cancer type 1 susceptibility protein-like isoform X1
ATP synthase subunit delta, mitochondrial
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X44
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X33
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X12
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X16
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X15
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X11
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X28
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X27
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X30
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X29
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X36
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X18
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X25
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X32
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X24
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X45
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X41
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X14
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X20
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X35
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X19
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X37
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X38
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X22
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X31
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X43
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X17
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X26
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X13
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X21
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X23
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X39
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X34
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X42
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X46
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X40
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X33
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X44
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X12
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X16
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X15
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X11
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X28
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X27
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X8
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X10
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X30
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X29
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X36
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X18
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X25
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X32
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X24
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X45
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X41
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X14
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X20
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X35
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X19
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X37
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X38
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X22
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X31
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X43
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X17
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X26
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X13
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X21
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X23
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X39
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X34
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X42
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X46
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X40
PR domain zinc finger protein 10-like, transcript variant X1
PR domain zinc finger protein 10-like, transcript variant X2
PR domain zinc finger protein 10-like isoform X1
PR domain zinc finger protein 10-like isoform X2
uncharacterized LOC124629595, transcript variant X2
uncharacterized LOC124629595, transcript variant X1
signal-induced proliferation-associated 1-like protein 1
cilia- and flagella-associated protein 44-like
electron transfer flavoprotein regulatory factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
putative uncharacterized protein DDB_G0282133
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L38, mitochondrial
pancreatic lipase-related protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
pancreatic lipase-related protein 2-like
coiled-coil domain-containing protein 170, transcript variant X1
coiled-coil domain-containing protein 170, transcript variant X2
coiled-coil domain-containing protein 170 isoform X1
coiled-coil domain-containing protein 170 isoform X2
uncharacterized LOC124629598, transcript variant X2
uncharacterized LOC124629598, transcript variant X3
uncharacterized LOC124629598, transcript variant X1
uncharacterized protein LOC124629598 isoform X1
uncharacterized protein LOC124629598 isoform X2
uridine phosphorylase 1, transcript variant X3
uridine phosphorylase 1, transcript variant X2
uridine phosphorylase 1, transcript variant X1
condensin-2 complex subunit D3-like, transcript variant X2
condensin-2 complex subunit D3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
condensin-2 complex subunit D3-like isoform X1
condensin-2 complex subunit D3-like isoform X2
uncharacterized LOC124630143, transcript variant X2
uncharacterized LOC124630143, transcript variant X1
uncharacterized protein LOC124630143 isoform X2
uncharacterized protein LOC124630143 isoform X1
coiled-coil domain-containing protein 97
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial import receptor subunit TOM70
uncharacterized LOC124629589, transcript variant X1
uncharacterized LOC124629589, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein KIAA1143 homolog
cleft lip and palate transmembrane protein 1 homolog
E3 ubiquitin-protein ligase RNF8-like, transcript variant X3
E3 ubiquitin-protein ligase RNF8-like, transcript variant X2
E3 ubiquitin-protein ligase RNF8-like, transcript variant X1
E3 ubiquitin-protein ligase RNF8-like isoform X3
E3 ubiquitin-protein ligase RNF8-like isoform X2
E3 ubiquitin-protein ligase RNF8-like isoform X1
E3 ubiquitin-protein ligase RNF8-like, transcript variant X5
E3 ubiquitin-protein ligase RNF8-like, transcript variant X4
E3 ubiquitin-protein ligase RNF8-like isoform X5
E3 ubiquitin-protein ligase RNF8-like isoform X4
uncharacterized LOC124629606, transcript variant X1
uncharacterized LOC124629606, transcript variant X2
immunoglobulin superfamily containing leucine-rich repeat protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase Ufd4, transcript variant X5
E3 ubiquitin-protein ligase Ufd4, transcript variant X6
E3 ubiquitin-protein ligase Ufd4, transcript variant X4
E3 ubiquitin-protein ligase Ufd4, transcript variant X3
E3 ubiquitin-protein ligase Ufd4, transcript variant X2
E3 ubiquitin-protein ligase Ufd4, transcript variant X1
E3 ubiquitin-protein ligase Ufd4 isoform X5
E3 ubiquitin-protein ligase Ufd4 isoform X6
E3 ubiquitin-protein ligase Ufd4 isoform X4
E3 ubiquitin-protein ligase Ufd4 isoform X3
E3 ubiquitin-protein ligase Ufd4 isoform X2
E3 ubiquitin-protein ligase Ufd4 isoform X1
thyrostimulin alpha-2 subunit, transcript variant X2
thyrostimulin alpha-2 subunit isoform X2
cytoplasmic dynein 2 light intermediate chain 1
thyrostimulin alpha-2 subunit, transcript variant X1
thyrostimulin alpha-2 subunit isoform X1
vacuolar protein sorting-associated protein 54
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
V-set and immunoglobulin domain-containing protein 1-like, transcript variant X3
V-set and immunoglobulin domain-containing protein 1-like, transcript variant X1
V-set and immunoglobulin domain-containing protein 1-like, transcript variant X2
V-set and immunoglobulin domain-containing protein 1-like isoform X1
V-set and immunoglobulin domain-containing protein 1-like isoform X2
V-set and immunoglobulin domain-containing protein 1-like isoform X3
rab3 GTPase-activating protein regulatory subunit
T-complex protein 1 subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
T-complex protein 1 subunit delta, transcript variant X1
T-complex protein 1 subunit delta isoform X1
T-complex protein 1 subunit delta isoform X2
mediator of RNA polymerase II transcription subunit 8
uncharacterized LOC124629748, transcript variant X1
uncharacterized protein LOC124629748 isoform X1
uncharacterized LOC124629748, transcript variant X2
uncharacterized protein LOC124629748 isoform X2
ribonucleoside-diphosphate reductase large subunit
tigger transposable element-derived protein 6-like
eukaryotic translation initiation factor 3 subunit K
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
ATP-dependent RNA helicase me31b, transcript variant X1
ATP-dependent RNA helicase me31b, transcript variant X2
E3 ubiquitin-protein ligase TRIM9, transcript variant X2
E3 ubiquitin-protein ligase TRIM9, transcript variant X1
E3 ubiquitin-protein ligase TRIM9 isoform X2
E3 ubiquitin-protein ligase TRIM9 isoform X1
uncharacterized LOC124630085, transcript variant X1
uncharacterized LOC124630085, transcript variant X2
uncharacterized protein LOC124630085 isoform X1
uncharacterized protein LOC124630085 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
acyl-CoA Delta-9 desaturase, transcript variant X2
acyl-CoA Delta-9 desaturase, transcript variant X1
pyrokinin-1 receptor-like, transcript variant X2
pyrokinin-1 receptor-like, transcript variant X1
(11Z)-hexadec-11-enoyl-CoA conjugase, transcript variant X2
(11Z)-hexadec-11-enoyl-CoA conjugase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
glutamyl aminopeptidase-like, transcript variant X1
glutamyl aminopeptidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins
uncharacterized transmembrane protein DDB_G0289901-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing and planar cell polarity effector protein fritz homolog
ubiquitin-60S ribosomal protein L40-like isoform X1
cytochrome c oxidase subunit 7A-related protein, mitochondrial-like
polyphosphoinositide phosphatase, transcript variant X1
polyphosphoinositide phosphatase, transcript variant X2
polyphosphoinositide phosphatase isoform X1
polyphosphoinositide phosphatase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC124630052, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC124630052, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 2
tyrosine-protein phosphatase 10D, transcript variant X1
tyrosine-protein phosphatase 10D, transcript variant X2
tyrosine-protein phosphatase 10D isoform X1
tyrosine-protein phosphatase 10D isoform X2
double-stranded RNA-binding protein Staufen homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X16
double-stranded RNA-binding protein Staufen homolog, transcript variant X10
double-stranded RNA-binding protein Staufen homolog, transcript variant X5
double-stranded RNA-binding protein Staufen homolog, transcript variant X15
double-stranded RNA-binding protein Staufen homolog, transcript variant X18
double-stranded RNA-binding protein Staufen homolog, transcript variant X12
double-stranded RNA-binding protein Staufen homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X17
double-stranded RNA-binding protein Staufen homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X4
double-stranded RNA-binding protein Staufen homolog, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog, transcript variant X19
double-stranded RNA-binding protein Staufen homolog, transcript variant X14
double-stranded RNA-binding protein Staufen homolog, transcript variant X9
double-stranded RNA-binding protein Staufen homolog, transcript variant X20
double-stranded RNA-binding protein Staufen homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
double-stranded RNA-binding protein Staufen homolog isoform X1
double-stranded RNA-binding protein Staufen homolog isoform X2
uncharacterized protein LOC124629783 isoform X4
uncharacterized protein LOC124629783 isoform X3
double-strand break repair protein MRE11
hrp65 protein-like, transcript variant X2
hrp65 protein-like, transcript variant X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase, transcript variant X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase, transcript variant X3
protein-L-isoaspartate(D-aspartate) O-methyltransferase, transcript variant X2
protein-L-isoaspartate(D-aspartate) O-methyltransferase
male-enhanced antigen 1, transcript variant X2
male-enhanced antigen 1, transcript variant X1
serine protease inhibitor 28Dc-like isoform X2
multidrug resistance-associated protein 1, transcript variant X3
multidrug resistance-associated protein 1, transcript variant X1
multidrug resistance-associated protein 1, transcript variant X4
multidrug resistance-associated protein 1, transcript variant X2
multidrug resistance-associated protein 1 isoform X4
multidrug resistance-associated protein 1 isoform X2
multidrug resistance-associated protein 1 isoform X3
multidrug resistance-associated protein 1 isoform X1
multidrug resistance-associated protein 1-like
RNA polymerase II transcriptional coactivator, transcript variant X1
RNA polymerase II transcriptional coactivator, transcript variant X4
RNA polymerase II transcriptional coactivator, transcript variant X2
RNA polymerase II transcriptional coactivator, transcript variant X3
RNA polymerase II transcriptional coactivator
alpha-aminoadipic semialdehyde synthase, mitochondrial
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial basic amino acids transporter-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat-containing protein 40-like
irregular chiasm C-roughest protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tyrosine-protein kinase transmembrane receptor Ror
zinc finger protein OZF-like, transcript variant X2
zinc finger protein OZF-like, transcript variant X1
uncharacterized LOC124629910, transcript variant X1
uncharacterized LOC124629910, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog
retinoid-inducible serine carboxypeptidase-like, transcript variant X1
retinoid-inducible serine carboxypeptidase-like, transcript variant X2
retinoid-inducible serine carboxypeptidase-like, transcript variant X3
retinoid-inducible serine carboxypeptidase-like, transcript variant X4
retinoid-inducible serine carboxypeptidase-like isoform X1
retinoid-inducible serine carboxypeptidase-like isoform X2
retinoid-inducible serine carboxypeptidase-like
DNA methyltransferase 1-associated protein 1
NADH dehydrogenase [ubiquinone] 1 subunit C2
thyrostimulin beta-5 subunit-like, transcript variant X1
thyrostimulin beta-5 subunit-like, transcript variant X2
thyrostimulin beta-5 subunit-like isoform X1
thyrostimulin beta-5 subunit-like isoform X2
thyrostimulin beta-5 subunit-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thyrostimulin beta-5 subunit-like isoform X3
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
trypsin, alkaline C-like, transcript variant X2
trypsin, alkaline C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
gastrula zinc finger protein XlCGF57.1-like
neuroendocrine protein 7B2, transcript variant X4
neuroendocrine protein 7B2, transcript variant X1
neuroendocrine protein 7B2, transcript variant X5
neuroendocrine protein 7B2, transcript variant X6
neuroendocrine protein 7B2, transcript variant X2
uncharacterized protein LOC124629918 isoform X3
neuroendocrine protein 7B2, transcript variant X3
uncharacterized LOC124629792, transcript variant X2
uncharacterized LOC124629792, transcript variant X1
uncharacterized protein LOC124629792 isoform X2
uncharacterized protein LOC124629792 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ell-associated factor Eaf, transcript variant X2
ell-associated factor Eaf, transcript variant X1
alpha,alpha-trehalose-phosphate synthase [UDP-forming]
anaphase-promoting complex subunit 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
anaphase-promoting complex subunit 11-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
anaphase-promoting complex subunit 11-like, transcript variant X1
uncharacterized protein LOC124629626 isoform X1
coiled-coil domain-containing protein 85C-B
RNA-binding protein 42, transcript variant X3
RNA-binding protein 42, transcript variant X2
RNA-binding protein 42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
VWFA and cache domain-containing protein CG16868
la-related protein 7, transcript variant X1
la-related protein 7, transcript variant X2
uncharacterized LOC124629923, transcript variant X3
uncharacterized LOC124629923, transcript variant X2
uncharacterized LOC124629923, transcript variant X1
uncharacterized protein LOC124629923 isoform X2
uncharacterized protein LOC124629923 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase classes I and II isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
carotenoid isomerooxygenase, transcript variant X2
carotenoid isomerooxygenase, transcript variant X1
medium-chain acyl-CoA ligase ACSF2, mitochondrial
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
mediator of RNA polymerase II transcription subunit 17
protein bark beetle, transcript variant X1
protein bark beetle, transcript variant X2
etoposide-induced protein 2.4 homolog, transcript variant X8
etoposide-induced protein 2.4 homolog, transcript variant X9
etoposide-induced protein 2.4 homolog isoform X2
etoposide-induced protein 2.4 homolog, transcript variant X5
etoposide-induced protein 2.4 homolog, transcript variant X4
etoposide-induced protein 2.4 homolog, transcript variant X1
etoposide-induced protein 2.4 homolog, transcript variant X7
etoposide-induced protein 2.4 homolog, transcript variant X6
etoposide-induced protein 2.4 homolog, transcript variant X3
etoposide-induced protein 2.4 homolog, transcript variant X2
uncharacterized protein LOC124629814 isoform X1
ATP-binding cassette subfamily G member 4, transcript variant X2
ATP-binding cassette subfamily G member 4 isoform X2
ATP-binding cassette subfamily G member 4, transcript variant X1
ATP-binding cassette subfamily G member 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
ATP-binding cassette sub-family G member 1-like
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
polypeptide N-acetylgalactosaminyltransferase 2-like
kinesin-like protein CG14535, transcript variant X1
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kinesin-like protein CG14535, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
chitooligosaccharidolytic beta-N-acetylglucosaminidase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: chitooligosaccharidolytic beta-N-acetylglucosaminidase
general transcription factor IIE subunit 2
spermidine synthase, transcript variant X3
phospholipid-transporting ATPase IF, transcript variant X5
phospholipid-transporting ATPase IF, transcript variant X3
phospholipid-transporting ATPase IF, transcript variant X4
phospholipid-transporting ATPase IF, transcript variant X6
phospholipid-transporting ATPase IF, transcript variant X7
phospholipid-transporting ATPase IF, transcript variant X1
phospholipid-transporting ATPase IF, transcript variant X2
phospholipid-transporting ATPase IF isoform X4
phospholipid-transporting ATPase IF isoform X1
phospholipid-transporting ATPase IF isoform X2
phospholipid-transporting ATPase IF isoform X3
spermidine synthase, transcript variant X1
spermidine synthase, transcript variant X2
remodeling and spacing factor 1, transcript variant X1
remodeling and spacing factor 1, transcript variant X8
remodeling and spacing factor 1, transcript variant X3
remodeling and spacing factor 1, transcript variant X5
remodeling and spacing factor 1, transcript variant X4
remodeling and spacing factor 1, transcript variant X2
remodeling and spacing factor 1, transcript variant X7
remodeling and spacing factor 1, transcript variant X6
remodeling and spacing factor 1, transcript variant X9
remodeling and spacing factor 1 isoform X1
remodeling and spacing factor 1 isoform X8
remodeling and spacing factor 1 isoform X3
remodeling and spacing factor 1 isoform X5
remodeling and spacing factor 1 isoform X4
remodeling and spacing factor 1 isoform X2
remodeling and spacing factor 1 isoform X7
remodeling and spacing factor 1 isoform X6
remodeling and spacing factor 1 isoform X9
uncharacterized LOC124629524, transcript variant X1
uncharacterized LOC124629524, transcript variant X2
uncharacterized protein LOC124629524 isoform X1
uncharacterized protein LOC124629524 isoform X2
retinoblastoma-binding protein 5 homolog, transcript variant X1
retinoblastoma-binding protein 5 homolog, transcript variant X2
retinoblastoma-binding protein 5 homolog isoform X2
retinoblastoma-binding protein 5 homolog isoform X1
CUGBP Elav-like family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
CUGBP Elav-like family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X3
CUGBP Elav-like family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CUGBP Elav-like family member 4, transcript variant X2
CUGBP Elav-like family member 4, transcript variant X6
CUGBP Elav-like family member 4 isoform X1
CUGBP Elav-like family member 4 isoform X4
CUGBP Elav-like family member 4 isoform X3
CUGBP Elav-like family member 4 isoform X2
CUGBP Elav-like family member 4 isoform X5
uncharacterized LOC124629526, transcript variant X1
uncharacterized LOC124629526, transcript variant X2
uncharacterized LOC124629526, transcript variant X4
uncharacterized LOC124629526, transcript variant X5
uncharacterized LOC124629526, transcript variant X3
uncharacterized protein LOC124629526 isoform X2
uncharacterized protein LOC124629526 isoform X3
uncharacterized protein LOC124629526 isoform X1
uncharacterized protein LOC124629526 isoform X4
uncharacterized protein LOC124629526 isoform X5
GRIP and coiled-coil domain-containing protein 1, transcript variant X1
GRIP and coiled-coil domain-containing protein 1, transcript variant X2
GRIP and coiled-coil domain-containing protein 1 isoform X2
GRIP and coiled-coil domain-containing protein 1 isoform X1
ATP-binding cassette subfamily G member 4, transcript variant X3
ATP-binding cassette subfamily G member 4 isoform X3
uncharacterized LOC124629620, transcript variant X3
uncharacterized LOC124629620, transcript variant X2
uncharacterized LOC124629620, transcript variant X1
uncharacterized protein LOC124629620 isoform X1
uncharacterized protein LOC124629620 isoform X2
uncharacterized LOC124629845, transcript variant X6
uncharacterized LOC124629845, transcript variant X1
uncharacterized LOC124629845, transcript variant X2
uncharacterized LOC124629845, transcript variant X5
uncharacterized LOC124629845, transcript variant X4
uncharacterized LOC124629845, transcript variant X9
uncharacterized LOC124629845, transcript variant X17
uncharacterized LOC124629845, transcript variant X11
uncharacterized LOC124629845, transcript variant X10
uncharacterized LOC124629845, transcript variant X12
uncharacterized LOC124629845, transcript variant X7
uncharacterized LOC124629845, transcript variant X8
uncharacterized LOC124629845, transcript variant X13
uncharacterized LOC124629845, transcript variant X16
uncharacterized LOC124629845, transcript variant X14
uncharacterized LOC124629845, transcript variant X15
uncharacterized LOC124629845, transcript variant X3
uncharacterized protein LOC124629845 isoform X2
uncharacterized protein LOC124629845 isoform X7
uncharacterized protein LOC124629845 isoform X11
uncharacterized protein LOC124629845 isoform X1
uncharacterized protein LOC124629845 isoform X4
uncharacterized protein LOC124629845 isoform X6
uncharacterized protein LOC124629845 isoform X10
uncharacterized protein LOC124629845 isoform X5
uncharacterized protein LOC124629845 isoform X8
uncharacterized protein LOC124629845 isoform X3
uncharacterized protein LOC124629845 isoform X12
uncharacterized protein LOC124629845 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein K02A2.6-like, transcript variant X1
uncharacterized protein K02A2.6-like, transcript variant X2
uncharacterized protein K02A2.6-like isoform X1
uncharacterized protein LOC124630010 isoform X2
DNA replication complex GINS protein PSF1-like
sphingosine-1-phosphate phosphatase 1-like
lysosomal-trafficking regulator, transcript variant X6
lysosomal-trafficking regulator, transcript variant X3
lysosomal-trafficking regulator, transcript variant X1
lysosomal-trafficking regulator, transcript variant X4
lysosomal-trafficking regulator, transcript variant X2
lysosomal-trafficking regulator isoform X5
uncharacterized protein LOC124629737 isoform X2
uncharacterized protein LOC124629737 isoform X1
uncharacterized protein LOC124629737 isoform X3
lysosomal-trafficking regulator, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124629737 isoform X4
uncharacterized LOC124629741, transcript variant X1
uncharacterized LOC124629741, transcript variant X2
uncharacterized LOC124629742, transcript variant X1
uncharacterized LOC124629742, transcript variant X2
U4/U6.U5 tri-snRNP-associated protein 1, transcript variant X1
U4/U6.U5 tri-snRNP-associated protein 1, transcript variant X2
U4/U6.U5 tri-snRNP-associated protein 1 isoform X1
U4/U6.U5 tri-snRNP-associated protein 1 isoform X2
WD repeat-containing protein on Y chromosome-like, transcript variant X3
WD repeat-containing protein on Y chromosome-like, transcript variant X2
WD repeat-containing protein on Y chromosome-like, transcript variant X1
WD repeat-containing protein on Y chromosome-like, transcript variant X4
WD repeat-containing protein on Y chromosome-like isoform X2
WD repeat-containing protein on Y chromosome-like isoform X1
WD repeat-containing protein on Y chromosome-like isoform X3
WD repeat-containing protein on Y chromosome-like isoform X4
uncharacterized LOC124629984, transcript variant X1
uncharacterized LOC124629984, transcript variant X2
WD repeat-containing protein on Y chromosome-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
28S ribosomal protein S21, mitochondrial
trafficking protein particle complex subunit 4
DNA-binding protein D-ETS-6-like, transcript variant X1
DNA-binding protein D-ETS-6-like isoform X1
DNA-binding protein D-ETS-6-like, transcript variant X2
DNA-binding protein D-ETS-6-like isoform X2
acetylcholine receptor subunit beta-type lev-1-like
ionotropic receptor 75a-like, transcript variant X1
ionotropic receptor 75a-like, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-B, transcript variant X2
solute carrier family 52, riboflavin transporter, member 3-B, transcript variant X1
solute carrier family 52, riboflavin transporter, member 3-B, transcript variant X4
solute carrier family 52, riboflavin transporter, member 3-B, transcript variant X3
solute carrier family 52, riboflavin transporter, member 3-B isoform X2
solute carrier family 52, riboflavin transporter, member 3-B isoform X1
solute carrier family 52, riboflavin transporter, member 3-B isoform X3
solute carrier family 52, riboflavin transporter, member 3-B isoform X4
serine palmitoyltransferase 2, transcript variant X1
serine palmitoyltransferase 2 isoform X1
serine palmitoyltransferase 2, transcript variant X2
serine palmitoyltransferase 2, transcript variant X3
serine palmitoyltransferase 2, transcript variant X4
serine palmitoyltransferase 2 isoform X2
serine palmitoyltransferase 2 isoform X3
serine palmitoyltransferase 2 isoform X4
uncharacterized LOC124629543, transcript variant X2
uncharacterized LOC124629543, transcript variant X1
chitinase-3-like protein 2, transcript variant X1
chitinase-3-like protein 2, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
LOW QUALITY PROTEIN: blastoderm-specific protein 25D
protein phosphatase 1 regulatory subunit 14B, transcript variant X2
protein phosphatase 1 regulatory subunit 14B, transcript variant X1
protein phosphatase 1 regulatory subunit 14B
serine/threonine-protein kinase grp, transcript variant X1
serine/threonine-protein kinase grp, transcript variant X4
serine/threonine-protein kinase grp, transcript variant X3
serine/threonine-protein kinase grp, transcript variant X2
serine/threonine-protein kinase grp isoform X2
serine/threonine-protein kinase grp isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: myosin-2 essential light chain-like
protein borderless, transcript variant X1
protein borderless, transcript variant X2